IBIO
iBio, Inc.
1.10$
-5.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.1% | +19.2% | -97.7% | +1,826.2% | +145.5% | -21.1% | -79.6% | +802.9% | -48.8% | -58.4% | +12.7% | +354.5% | -18.8% | +44.7% | -20.5% | -97.3% | +350.0% | +77.8% | -75.0% | |
| – | +8.8% | +3.2% | -32.7% | +11.8% | +2,603.5% | -28.0% | -26.0% | +50.3% | +21.4% | +31.2% | -0.2% | – | – | +108.0% | +159.3% | -70.8% | +13.0% | – | – | |
| – | +11.4% | -21.9% | – | – | +145.5% | -21.1% | -79.6% | +802.9% | -48.8% | -58.4% | +12.7% | +354.5% | -53.7% | -2.8% | -309.8% | – | +350.0% | +77.8% | -75.0% | |
| – | -18.3% | +45.0% | +215.7% | +22.5% | +61.5% | -31.1% | -44.7% | +84.1% | -9.7% | +30.4% | -3.2% | +37.3% | -34.7% | +179.6% | -1.6% | +5.1% | -49.8% | +60.3% | +136.3% | |
| – | – | -0.7% | +14.7% | +242.6% | -20.7% | -24.5% | -1.1% | +19.7% | +53.0% | +37.3% | +1.3% | +15.4% | -7.8% | +90.9% | +0.3% | -12.6% | -38.6% | -8.4% | -0.9% | |
| – | +11.9% | +9.9% | +63.3% | +139.4% | +0.1% | -24.7% | -47.3% | +110.6% | +27.3% | +35.3% | +0.0% | +21.4% | -16.1% | +114.4% | -13.2% | +5.6% | -42.5% | +12.7% | +85.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +285.2% | +24.4% | +43.2% | +35.6% | -100.0% | – | +139.0% | -0.7% | -0.8% | +29.8% | -0.5% | -42.5% | -94.1% | +107.2% | +23.3% | -75.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +336.0% | -58.8% | +57.1% | +103,566.7% | -246.7% | – | -62.5% | -120.0% | – | – | -90.2% | -111.8% | – | -98.1% | +1,423.9% | -271.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.